Authors:
Okada, H
Villa, L
Attanucci, J
Erff, M
Fellows, WK
Lotze, MT
Pollack, IF
Chambers, WH
Citation: H. Okada et al., Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells, GENE THER, 8(15), 2001, pp. 1157-1166
Authors:
Nakahara, N
Okada, H
Witham, TF
Attanucci, J
Fellows, WK
Chambers, WH
Niranjan, A
Kondziolka, D
Pollack, IF
Citation: N. Nakahara et al., Combination of stereotactic radiosurgery and cytokine gene-transduced tumor cell vaccination: a new strategy against metastatic brain tumors, J NEUROSURG, 95(6), 2001, pp. 984-989
Authors:
Okada, H
Attanucci, J
Giezeman-Smits, KM
Brissette-Storkus, C
Fellows, WK
Gambotto, A
Pollack, IF
Pogue-Geile, K
Lotze, MT
Bozik, ME
Chambers, WH
Citation: H. Okada et al., Immunization with an antigen identified by cytokine tumor vaccine-assistedSEREX (CAS) suppressed growth of the rat 9L glioma in vivo, CANCER RES, 61(6), 2001, pp. 2625-2631
Authors:
Okada, H
Attanucci, J
Tahara, H
Pollack, IF
Bozik, ME
Chambers, WH
Lotze, MT
Citation: H. Okada et al., Characterization and transduction of a retroviral vector encoding human interleukin-4 and herpes simplex virus-thymidine kinase for glioma tumor vaccine therapy, CANC GENE T, 7(3), 2000, pp. 486-494
Authors:
Giezeman-Smits, KM
Okada, H
Brissette-Storkus, CS
Villa, LA
Attanucci, J
Lotze, MT
Pollack, IF
Bozik, ME
Chambers, WH
Citation: Km. Giezeman-smits et al., Cytokine gene therapy of gliomas: Induction of reactive CD4(+) T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity, CANCER RES, 60(9), 2000, pp. 2449-2457
Authors:
Okada, H
Giezeman-Smits, KM
Tahara, H
Attanucci, J
Fellows, WK
Lotze, MT
Chambers, WH
Bozik, ME
Citation: H. Okada et al., Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine, GENE THER, 6(2), 1999, pp. 219-226
Authors:
Hagenaars, M
Ensink, NG
Jonges, LE
Chambers, WH
Eggermont, AMM
van de Velde, CJH
Fleuren, GJ
Kuppen, PJK
Citation: M. Hagenaars et al., The development of a bi-specific anti-CD 161AxAnti-tumor antibody for rat NK cell targeting, IMMUNOBIOL, 200(1), 1999, pp. 31-48
Authors:
Neipp, M
Gammie, JS
Exner, BG
Li, S
Chambers, WH
Pham, SM
Ildstad, ST
Citation: M. Neipp et al., A partial conditioning approach to achieve mixed chimerism in the rat: Depletion of host natural killer cells significantly reduces the amount of total body irradiation required for engraftment, TRANSPLANT, 68(3), 1999, pp. 369-378
Authors:
Bezouska, K
Vlahas, G
Horvath, O
Jinochova, G
Fiserova, A
Giorda, R
Chambers, WH
Feizi, T
Pospisil, M
Citation: K. Bezouska et al., Rat natural killer cell antigen, NKR-PI, related to C-type animal lectins is a carbohydrate-binding protein (vol 269, pg 16945, 1994), J BIOL CHEM, 274(42), 1999, pp. 30335-30336
Authors:
Metes, D
Manciulea, M
Pretrusca, D
Rabinowich, H
Ernst, LK
Popescu, L
Calugaru, A
Sulica, A
Chambers, WH
Herberman, RB
Morel, PA
Citation: D. Metes et al., Ligand binding specificities and signal transduction pathways of Fc gamma receptor IIc isoforms: the CD32 isoforms expressed by human NK cells, EUR J IMMUN, 29(9), 1999, pp. 2842-2852
Authors:
Quan, N
Zhang, ZB
Demetrikopoulos, MK
Kitson, RP
Chambers, WH
Goldfarb, RH
Weiss, JM
Citation: N. Quan et al., Evidence for involvement of B lymphocytes in the surveillance of lung metastasis in the rat, CANCER RES, 59(5), 1999, pp. 1080-1089